LGDN.STU LIGAND PHARMA (LGDN.SG)

Other Metals & Mining Stuttgart Exchange
- EUR
Market cap
-
P/E
130.8x
P/B
6.68x
ROE
7.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is LGDN.STU undervalued?

Graham number

The Graham number of LIGAND PHARMA (LGDN.SG) cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

LIGAND PHARMA (LGDN.SG) fundamental analysis

No fundamental analysis for LIGAND PHARMA (LGDN.SG) yet.

LIGAND PHARMA (LGDN.SG) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About LIGAND PHARMA (LGDN.SG)

There is no Profile data available for LGDN.SG.

Full company profile